Brazil's Anvisa spreads wings further with German health protection research collaboration
This article was originally published in Clinica
Brazil’s healthcare products regulatory agency (Anvisa) and Germany’s federal institute for risk assessment (BfR) have agreed to work together in the field of risk assessment related to health protection. The two bodies signed a research collaboration and information-sharing agreement on 24 May, in a move that reflects the growing international reach and influence of Anvisa’s work. The BfR’s remit is to identify and assess existing and new health risks posed by products, substances and foodstuffs; it reports to Germany’s food, agriculture and consumer protection ministry (BMELV), but provides scientific advice to the relevant federal ministries.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.